<p>Only DMDs used in at least 10 SMSC patients and with at least 1 year of mean follow-up are shown.</p
<p>RRMS = Relapsing-remitting Multiple Sclerosis, Pub.Year = Year of Publication, N = patients in pl...
Background Discontinuation of injectable diseasemodifying therapy (DMT) for multiple sclerosis (MS) ...
<p>Association of vitamin D status and relapses (yes/no) during three year follow-up in RRMS-onset p...
<p>RRF = Rate of relapse free patients after 2 years, SE = Standard error, ARR = Annualized re...
†<p>Mean (±SD).</p>§<p>Median (range).</p><p>The annualized relapse rate (ARR) during the last year ...
Cohort of RRMS patients after relapse treated with either Tecfidera or Beta Interferon who underwent...
<p>DMT: disease-modifying therapy; PDDS: Patient Determined Disease Steps scale; RRMS: relapsing-rem...
<p>Association of vitamin D status and relapses (yes/no) during three year follow-up in RRMS-onset p...
<p>Association of vitamin D status and relapses (yes/no) during three year follow-up in RRMS-onset p...
<p>Data are shown as mean (+/- SD)</p><p>Demographics of patients with relapsing- remitting (RR) / s...
<p>Proportion of RRMS patients with not evidence of disease activity (NEDA) under treatment with RTX...
<p>F = female; LP = lumbar puncture time; EDSS = Expanded Disability Status Scale; ΔEDSS = differenc...
Discontinuation of injectable disease-modifying therapy (DMT) for multiple sclerosis (MS) after a lo...
<p>Number of male and female RRMS/SPMS patients who provided at least one valid EDSS measurement in ...
Background and objectivesWhile randomized, controlled trials (RCTs) are the gold standard for determ...
<p>RRMS = Relapsing-remitting Multiple Sclerosis, Pub.Year = Year of Publication, N = patients in pl...
Background Discontinuation of injectable diseasemodifying therapy (DMT) for multiple sclerosis (MS) ...
<p>Association of vitamin D status and relapses (yes/no) during three year follow-up in RRMS-onset p...
<p>RRF = Rate of relapse free patients after 2 years, SE = Standard error, ARR = Annualized re...
†<p>Mean (±SD).</p>§<p>Median (range).</p><p>The annualized relapse rate (ARR) during the last year ...
Cohort of RRMS patients after relapse treated with either Tecfidera or Beta Interferon who underwent...
<p>DMT: disease-modifying therapy; PDDS: Patient Determined Disease Steps scale; RRMS: relapsing-rem...
<p>Association of vitamin D status and relapses (yes/no) during three year follow-up in RRMS-onset p...
<p>Association of vitamin D status and relapses (yes/no) during three year follow-up in RRMS-onset p...
<p>Data are shown as mean (+/- SD)</p><p>Demographics of patients with relapsing- remitting (RR) / s...
<p>Proportion of RRMS patients with not evidence of disease activity (NEDA) under treatment with RTX...
<p>F = female; LP = lumbar puncture time; EDSS = Expanded Disability Status Scale; ΔEDSS = differenc...
Discontinuation of injectable disease-modifying therapy (DMT) for multiple sclerosis (MS) after a lo...
<p>Number of male and female RRMS/SPMS patients who provided at least one valid EDSS measurement in ...
Background and objectivesWhile randomized, controlled trials (RCTs) are the gold standard for determ...
<p>RRMS = Relapsing-remitting Multiple Sclerosis, Pub.Year = Year of Publication, N = patients in pl...
Background Discontinuation of injectable diseasemodifying therapy (DMT) for multiple sclerosis (MS) ...
<p>Association of vitamin D status and relapses (yes/no) during three year follow-up in RRMS-onset p...